Navigation Links
DaVita Commends Kidney Care Partners for Launch of PEAK Campaign

Programs Designed to Address High Risks for New Dialysis Patients Making a Difference in Cutting Patient Mortality Rates

DENVER, June 9 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today commended Kidney Care Partners for launching the Performance Excellence and Accountability in Kidney Care (PEAK) campaign. Kidney Care Partners - a coalition of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with CKD - designed the project to significantly reduce the high mortality rate for patients in their first year of dialysis.


Due to complexities involved in starting dialysis - including dietary changes, vascular access management and adjusting to a regular treatment schedule, among many other factors - patients are at their most susceptible to complications during their initial transition to dialysis. PEAK is a quality improvement campaign pledging to extend, even save, as many as 10,000 lives and reduce mortality among first-year dialysis patients by 20 percent by the end of 2012.

"The kidney care community has achieved wonderful and demonstrable quality improvements in the last 10 years, and PEAK is now being launched to help us achieve the same in the next 10 years," said Kent Thiry, Chairman and Chief Executive Officer of DaVita(R). "When dialysis patients are at their most vulnerable, PEAK will work with leading researchers and experts to provide recommendations on care and education necessary to help make a difference in the lives of countless patients and their families. DaVita applauds the work of all members of Kidney Care Partners and looks forward to working together to provide even better outcomes for new dialysis patients."

As part of DaVita's commitment to continuous quality improvement, the company recently announced similar efforts with the company's IMPACT(TM) (Incident Management of Patients, Actions Centered on Treatment) pilot program. In a study presented at the National Kidney Foundation's Spring Clinical Meeting in Nashville, TN, DaVita researchers detailed how the IMPACT patient care model educates and manages dialysis patients within the first 90 days of treatment, when they are most unstable and are at highest risk. Data reflects a reduction in annualized mortality rates by eight percent for IMPACT patients compared with non-IMPACT patients in the DaVita network.

DaVita and IMPACT are trademarks or registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. Recognized as the only FORTUNE 500(R) company on WorldBlu's annual List of Most Democratic Work Places(TM), DaVita manages more than 1,475 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 114,000 patients - nearly one-in-three of all dialysis patients in the United States. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit

SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DaVitas Kidney Calculator iPhone App Downloaded in 24 Countries
2. DaVita Extends Lease to Maintain Strong Business Presence in Tacoma
3. Pamela M. Arway Joins DaVita Board of Directors
4. DaVita Announces New Corporate Headquarters in Denver, Colorado
5. DaVita Wins Eight Hermes Creative Awards Recognizing Excellence in Communications and Marketing
6. DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership
7. DaVita Announces Completion of Government Investigation
8. DaVita Donates More Than $1 Million in Scholarship Funds for Teammates Families
9. DaVita 1st Quarter 2009 Results
10. DaVita Wins Silver in Web Health Awards
11. DaVita Honored as First and Only FORTUNE 500 Company to Make List of Democratic Workplaces Since Its Inception in 1999
Post Your Comments:
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... (AIS) is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three ... learned from three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. The purchase ... technical experience available within DataTrade to extend the services currently provided by Healthjump. ...
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... ), a leading provider of enterprise Time and Attendance/Workforce Management cloud-based ... in the Microsoft Partner Program with competencies in the Application Development, demonstrating ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... 2016. In 2016, expected coding changes are likely to include new codes for ... It’s not easy to understand the effects of code changes in musculoskeletal, radiology ...
(Date:11/29/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... Women's Excellence is once again accredited by the American Institute ... peer review process that allows practices to demonstrate that they meet or ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015  Novartis will demonstrate the strength ... th American Society of Hematology (ASH) Annual Meeting. ... as well as supportive care, including key findings in ... cell therapies. The ASH Annual Meeting will be held ... Novartis Oncology . "We will be presenting ...
(Date:11/30/2015)... BOSTON , November 30, 2015 ... new medicines directed at up to 10 G protein-coupled ... PFE ) to research and develop potential new ... (GPCR) targets across multiple therapeutic areas. --> ... and development company and wholly-owned subsidiary of Sosei Group ...
(Date:11/30/2015)... , November 30, 2015 ... or the "Company") announced today that it was informed by ... and Drug Safety (MFDS) has approved its Exablate Neuro ... --> --> Insightec,s Exablate ... treatment alternative that combines two technologies: Focused Ultrasound, which ...
Breaking Medicine Technology: